: Certain compounds like Sunifiram (an ampakine-like modulator) are listed by specialized scientific suppliers such as Biosynth , but these are strictly for laboratory research and are priced at roughly $900 per 5g.
If you are tracking these for potential future availability, the following are the primary "active" candidates in the clinical pipeline: Preclinical Pharmacology of the Low-Impact Ampakine CX717 buy ampakines
: RespireRx Pharmaceuticals currently leads development for compounds like CX1739 and CX717, primarily targeting ADHD and opioid-induced respiratory depression. While they remain highly active in clinical research
Current market intelligence (as of April 2026) indicates that through standard retail or pharmaceutical channels, as no compounds in this class have received FDA approval . While they remain highly active in clinical research for ADHD and spinal cord injuries, they are largely confined to experimental and institutional settings. Current Availability and Market Status buy ampakines